EUGENE
Business purpose.
Promotion et distribution de tests médicaux.
Identity
- Legal form
- SARL (no further detail)
- Activity
- Research and experimental development on biotechnology (72.11Z)
- Sector
- Scientific research and development
- Headcount
- Headcount unknown
- Created
- 29 Sep 2020
- Share capital
- 5,000.00 EUR
- Registered with the trade register
- 23 Oct 2020
- Financial year end
- 31/12
- Establishments
- 2
Directors
- RONY El Khoury 61 years old, 07/1965 Gerant
Other companies at the same address
76 other company head offices are registered at this address.
Establishments
-
89029633800019 75015 PARIS
Financial strength
Financial score
51 / 100 C
Confidence: high · computed on the financial year ended 31 Dec 2025
- Equity to assets (34.7 %)
- 13.7 out of 30
- EBITDA margin (5.9 %)
- 12.2 out of 25
- Liquidity (35.4 %)
- 0.4 out of 20
- Debt (0.0 %)
- 15.0 out of 15
- Revenue trend (41.5 %)
- 10.0 out of 10
formula fin-1.0
Legal score
92 / 100 A
Confidence: high
- No insolvency proceedings
- 40.0 out of 40
- Currently trading
- 20.0 out of 20
- Age (6.1 years)
- 12.3 out of 20
- Accounts filed recently
- 20.0 out of 20
formula leg-1.0
These scores are computed by us from public data, using a published formula. They are not advice, not a guarantee, not a credit decision, and they do not replace a review of the accounts. See how it is calculated
Revenue and earnings
Detailed accounts for this company are not reproduced here, but its main aggregates are public.
Revenue Net income
| Financial year | Revenue | Change | EBITDA | Net income |
|---|---|---|---|---|
| 31 Dec 2025 | 385,061 € | +41.5 % | 22,808 € | 15,152 € |
| 31 Dec 2024 | 272,194 € | +29.6 % | 14,277 € | 11,453 € |
| 31 Dec 2023 | 209,962 € | +60.3 % | 5,060 € | 2,792 € |
| 31 Dec 2022 | 130,999 € | +332.2 % | 11,836 € | 9,357 € |
| 31 Dec 2021 | 30,308 € | first year on record | -11,497 € | -11,973 € |
Aggregates published by the French Directorate General for Enterprise, computed from accounts filed with the commercial court.
Explore similar companies
Legal notices
-
Filing of accounts 3 Jun 2026
- Court :
- Greffe du Tribunal des Activités Economiques de paris
- Type of filing :
- Comptes annuels et rapports
- Closing date :
- 31/12/2025
BODACC C n 20260103, annonce n 1575 · Proof of publication (PDF)
-
Filing of accounts 6 Mar 2025
- Court :
- Greffe du Tribunal des Activités Economiques de paris
- Type of filing :
- Comptes annuels et rapports
- Closing date :
- 31/12/2024
BODACC C n 20250046, annonce n 10815 · Proof of publication (PDF)
-
Filing of accounts 16 Jun 2024
- Court :
- Greffe du Tribunal de Commerce de paris
- Type of filing :
- Comptes annuels et rapports
- Closing date :
- 31/12/2023
BODACC C n 20240115, annonce n 5024 · Proof of publication (PDF)
-
Filing of accounts 6 Jun 2023
- Court :
- Greffe du Tribunal de Commerce de paris
- Type of filing :
- Comptes annuels et rapports
- Closing date :
- 31/12/2022
BODACC C n 20230107, annonce n 3835 · Proof of publication (PDF)
-
Filing of accounts 31 May 2023
- Court :
- Greffe du Tribunal de Commerce de paris
- Type of filing :
- Comptes annuels et rapports
- Closing date :
- 31/12/2021
BODACC C n 20230104, annonce n 4048 · Proof of publication (PDF)
Change history
- officer_appointed (empty) → Gerant 9 Oct 2026
Frequently asked questions about EUGENE
- What is the SIREN number of EUGENE?
- The SIREN number of EUGENE is 890296338. Its intra-community VAT number is FR40890296338.
- Where is the head office of EUGENE?
- Head office address: 181 AVENUE VICTOR HUGO, 75016 PARIS.
- When was EUGENE founded?
- EUGENE was founded on 29 Sep 2020.
- What does EUGENE do?
- Its declared main activity is: Research and experimental development on biotechnology (NAF code 72.11Z).
- Who runs EUGENE?
- The officer listed in the register is RONY El Khoury (Gerant).
- What is the revenue of EUGENE?
- The latest published revenue is 385,061 €, for the 2025 financial year.
- Is EUGENE subject to insolvency proceedings?
- No ongoing insolvency proceedings are published in the BODACC for this company.